1
Novel Desensitization Kidney Transplantation
Condition(s):Kidney Transplantation; End Stage Kidney Disease (ESRD)Last Updated:May 19, 2022Recruiting
Proteasome Inhibitor: 222 Clinical Trials, Page 1 of 23
Hide Studies Not Open or Pending
2
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma
Condition(s):CancerLast Updated:March 26, 2012Withdrawn
3
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
Condition(s):MyelomaLast Updated:June 26, 2019Completed
4
An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD
Condition(s):Multiple MyelomaLast Updated:June 25, 2018Completed
5
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
Condition(s):AML; AML, AdultLast Updated:March 31, 2022Terminated
6
A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent
Condition(s):Multiple MyelomaLast Updated:August 16, 2022Completed
7
Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:November 3, 2022Recruiting
8
A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy
Condition(s):Relapsed and/or Refractory Multiple MyelomaLast Updated:September 27, 2022Completed
9
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies
Condition(s):Waldenstrom’s Macroglobulinemia; Non-Hodgkin’s Lymphoma; Hodgkin’s Disease; Multiple MyelomaLast Updated:May 2, 2017Completed
10
Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy
Condition(s):Lymphoma, B-CellLast Updated:October 31, 2018Completed